Stephan Chalon

A controlled human malaria infection model enabling evaluation of transmission-blocking interventions

Katharine A. Collins, Claire Wang, Matthew Adams et al. · Journal of Clinical Investigation · 2018 · 129 citations · Full text

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study

James McCarthy, Julie Lotharius, Thomas Rückle et al. · The Lancet Infectious Diseases · 2017 · 124 citations · Full text

DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection

Mihály Sulyok, Thomas Rückle, Alexandra Roth et al. · The Lancet Infectious Diseases · 2017 · 103 citations · Full text

Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study

Stephan Chalon, Luc‐André Granier, François Vandenhende et al. · Neuropsychopharmacology · 2003 · 94 citations · Full text

Psychoactive Drug, Healthy Subjects, Psychiatry +13

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects

Richat Abbas, Bruce A. Hug, Cathie Leister et al. · Cancer Chemotherapy and Pharmacology · 2011 · 83 citations

Drug Safety, Pharmacology, Healthy Adult Subjects +5